Zydus gets USFDA nod for generic medication
Thursday, 25 January 2024
The drug maker is the first company to receive final approval for generic Gabapentin tablets (300 mg and 600 mg), it added. The product will be launched immediately in the US market, the drug firm stated.
The drug maker is the first company to receive final approval for generic Gabapentin tablets (300 mg and 600 mg), it added. The product will be launched immediately in the US market, the drug firm stated.
|
||||
💡 newsR Knowledge: Other News MentionsYou Might Like |